2008年
- Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
Mimori K, Ishii H, Inoue H, Barnard GF, Mori M.
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S205-9. doi: 10.1111/j.1440-1746.2008.05439.x. - Clinical significance of ApoE expression in human gastric cancer.
Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M.
Oncol Rep. 2008 Dec;20(6):1313-9. - Cancer stem cells and chemoradiation resistance.
Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, Mori M.
Cancer Sci. 2008 Oct;99(10):1871-7. doi: 10.1111/j.1349-7006.2008.00914.x. Review. - Clinical significance of low expression of Prostasin mRNA in human gastric cancer.
Sakashita K, Mimori K, Tanaka F, Tahara K, Inoue H, Sawada T, Ohira M, Hirakawa K, Mori M.
J Surg Oncol. 2008 Dec 1;98(7):559-64. doi: 10.1002/jso.21158. - Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
Yoshinaga K, Mimori K, Inoue H, Kamohara Y, Yamashita K, Tanaka F, Mori M.
Int J Oncol. 2008 Sep;33(3):453-9. - CD133+CD44+ population efficiently enriches colon cancer initiating cells.
Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M.
Ann Surg Oncol. 2008 Oct;15(10):2927-33. doi: 10.1245/s10434-008-0074-0. Epub 2008 Jul 29. - A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori T, Hirasaki S, Takatsuno Y, Sakashita H, Ishii H, Sasako M, Mori M.
Ann Surg Oncol. 2008 Oct;15(10):2934-42. doi: 10.1245/s10434-008-9916-z. Epub 2008 Jul 26. - The search for cancer stem cells in hepatocellular carcinoma.
Kamohara Y, Haraguchi N, Mimori K, Tanaka F, Inoue H, Mori M, Kanematsu T.
Surgery. 2008 Aug;144(2):119-24. doi: 10.1016/j.surg.2008.04.008. - Prognostic relevance of Tensin4 expression in human gastric cancer.
Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M.
Ann Surg Oncol. 2008 Sep;15(9):2606-13. doi: 10.1245/s10434-008-9989-8. Epub 2008 Jul 9. - Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib.
Zhang X, Nagahara H, Mimori K, Inoue H, Sawada T, Ohira M, Hirakawa K, Mori M.
Oncol Rep. 2008 Jun;19(6):1541-4. - Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes.
Ishii H, Mimori K, Ishikawa K, Okumura H, Pichiorri F, Druck T, Inoue H, Vecchione A, Saito T, Mori M, Huebner K.
Cancer Res. 2008 May 15;68(10):3662-70. doi: 10.1158/0008-5472.CAN-07-5687. - PDGF-BB is a novel prognostic factor in colorectal cancer.
Nakamura Y, Tanaka F, Yoshikawa Y, Mimori K, Inoue H, Yanaga K, Mori M.
Ann Surg Oncol. 2008 Aug;15(8):2129-36. doi: 10.1245/s10434-008-9943-9. Epub 2008 May 14. - Clinical significance of loss of Fhl1 expression in human gastric cancer.
Sakashita K, Mimori K, Tanaka F, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M.
Ann Surg Oncol. 2008 Aug;15(8):2293-300. doi: 10.1245/s10434-008-9904-3. Epub 2008 May 9. - Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1.
Mimori K, Fukagawa T, Kosaka Y, Kita Y, Ishikawa K, Etoh T, Iinuma H, Sasako M, Mori M.
Clin Cancer Res. 2008 May 1;14(9):2609-16. doi: 10.1158/1078-0432.CCR-07-4354. - Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Yokoe T, Tanaka F, Mimori K, Inoue H, Ohmachi T, Kusunoki M, Mori M.
Cancer Res. 2008 Feb 15;68(4):1074-82. doi: 10.1158/0008-5472.CAN-07-0964. - Clinical significance of BMP7 in human colorectal cancer.
Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8. - Biological and genetic characteristics of tumor-initiating cells in colon cancer.
Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H, Mori M.
Ann Surg Oncol. 2008 Feb;15(2):638-48. Epub 2007 Oct 12. - Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, Mori M.
Ann Surg Oncol. 2008 Jan;15(1):96-103. Epub 2007 Oct 2.